Concepedia

Van‐Duc Le

VL

14

Publications

317

Citations

13

H-Index

1999

Active since

Affiliations

Albany Molecular Research (United States)(Current)

Scripps Research Institute

Imperial College London

Pfizer (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Van‐Duc Le is an author at Albany Molecular Research (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1999–2011

14

Publications

14

Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants

Taekyu Lee, Van‐Duc Le, Dongyeol Lim et al. · Journal of the American Chemical Society · 1999 · 57 citations

, , +20

Novel Cyclopropyl β-Amino Acid Analogues of Pregabalin and Gabapentin That Target the α<sub>2</sub>-δ Protein

Jacob B. Schwarz, Sian E. Gibbons, Shelley R. Graham et al. · Journal of Medicinal Chemistry · 2005 · 45 citations

, , +18

Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease

Ying‐Chuan Lin, Zachary Q. Beck, Taekyu Lee et al. · Journal of Virology · 2000 · 26 citations · Full text

Synthesis of 2-Substituted Polyhydroxytetrahydropyrimidines (<i>N</i>-Hydroxy Cyclic Guanidino-Sugars):  Transition-State Mimics of Enzymatic Glycosidic Cleavage

Van‐Duc Le, Chi‐Huey Wong · The Journal of Organic Chemistry · 2000 · 23 citations

, , +15

3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT6 receptor modulators

Ronald C. Bernotas, Schuyler Antane, Rajesh Shenoy et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 22 citations · Full text

, , +5

Rows per page

1–5 of 14